Physician profile
Andrew J Vorenberg
NPI 1699988170
$559,524.48
in general payments reported to CMS, 2019-2025
22 companies · $40K in 2025
The $40K reported for 2025 was more than what 98% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $63K · 2021: $79K · 2022: $130K · 2023: $92K · 2024: $38K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $132K · Travel and Lodging: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,800 · Food and Beverage: $1,686 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $132,400.00 |
| Travel and Lodging | $30,943.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,800.00 |
| Food and Beverage | $1,685.73 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $556,838.67 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Applied Medical Resources Corporation | $762.45 | 2019 | |
| Medtronic, INC. | $423.85 | 2022-2024 | Interstim, Gi Genius, Ligasure |
| Ethicon US, LLC | $338.44 | 2020-2023 | Echelon Flex |
| Medtronic USA, INC. | $172.03 | 2019 | |
| Stryker Corporation | $166.98 | 2019 | |
| Braintree Laboratories, INC. | $138.12 | 2019-2021 | |
| Ethicon INC. | $100.00 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $86.10 | 2024-2025 | Exparel |
| Thd America, INC. | $85.35 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $72.74 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.11 | 2019-2023 | Bridion |
| Boston Scientific Corporation | $49.61 | 2025 | Wavewriter Alpha Prime 16 |
| Covidien Lp | $47.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $39.01 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.13 | 2021 | |
| Sanara Medtech INC. | $20.11 | 2025 | Celleraterx |
| Mimedx Group, INC. | $14.22 | 2024 | |
| Davol INC. | $13.93 | 2021 | |
| Baudax Bio INC. | $12.27 | 2020 | |
| La Jolla Pharmaceutical Company | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Vorenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.